Summary
ω-Conotoxin GVIA (ω-CT) diminished the potassium-induced in vitro release of 3H-γ-aminobutyric acid (3H-GABA) from slices of rat neostriatum in a manner which depended on the concentration of potassium. ω-CT (0.1 nmol/l) decreased the release of 3H-GABA induced by 25 mmol/l K+ from 11.6% to 6.1% of tissue content, ie. by 48%, while it did not affect the release of 3H-GABA caused by 20 mmol/l K+, which was 4.8% of tissue content. However, in the presence of a polyclonal antiserum or cysteamine (600 μmol/l), both of which diminish the effects of endogenous somatostatin, 0.1–10 nmol/l ω-CT decreased the release of 3H-GABA induced by 20 mmoles/l K+ by 40%. It is concluded that ω-CT did not only inhibit GABA-neurones, but had an additional inhibitory effect on somatostatin neurones which are known to depress the release of 3H-GABA. It is further concluded that neuronal interactions, which are possible in brain slice preparations, may impede the interpretation of effects of drugs, especially if agents are used which affect basic mechanisms of transmitter release and thus the release of various transmitters from neurones.
This is a preview of subscription content, log in via an institution to check access.
References
Bhakit C, Benoit R, Bloom FE (1983) Effects of cysteamine on prosomatostatin releated peptides. Regul Peptides 6:169–177
Cunningham JO, Neal MJ (1981) On the mechanism by which veratridine causes a calcium-independent release of γ-aminobutyric acid from brain slices. Br J Pharmacol 73:655–667
Dooley DJ, Lupp A, Hertting G (1987) Inhibition of central neurotransmitter release by ω-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium-channel. Naunyn-Schmiedeberg's Arch Pharmacol 336:467–470
Dooley DJ, Lupp A, Hertting G, Osswald H (1988) ω-Conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release. Eur J Pharmacol 148:261–267
Hirning LD, Fox AP, McCleskey EW, Olivera BM, Thayer SA, Miller RJ, Tsien RW (1988) Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 239:57–61
Katz B, Miledi R (1967) A study of synaptic transmission in the absence of nerve impulses. J Physiol 192:407–436
Keith RA, Mangano TJ, Pacheco MA, Salama AI (1988) The effects of the N-type voltage-sensitive calcium-channel (VSCC) modulator, ω-conotoxin GVIA (ω-CT) on central and peripheral neurotransmitter release. FASEB J 2: A798, 2915
Kernel ML, Gauchy C, Glowinsky J, Besson MJ (1979) Spontaneous and potassium evoked release of 3H-GABA newly synthesized from 3H-glutamine in slices of rat substantia nigra. Life Sci 24:2139–2150
Kerr LM, Yoshikami D (1984) A venom peptide with a novel presynaptic blocking action. Nature 308:282–284
Meyer DK, Conzelmann U, Schultheiss K (1989) Effects of somatostatin-14 on the in vitro release of 3H-GABA from slices of rat caudatoputamen. Neuroscience 28:61–68
Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, de Sates V, Cruz Lj (1985) Peptide neurotoxins from fish-hunting cone snails. Science 230:1338–1343
Reynolds IL, Wagner JA, Snyder SH, Thayer SA, Olivera BM, Miller RJ (1986) Brain voltage-sensitive calcium channel subtypes differentiated by ω-conotoxin fraction GVIA. Proc Natl Acad Sci 83:8804–8807
Widman R, Sperk G (1987) Cysteamine-induced decrease of somatostatin in rat brain synaptosomes in vitro. Endocrinology 121:1383–1389
Author information
Authors and Affiliations
Additional information
Send offprint requests to D. K. Meyer at the above address
Rights and permissions
About this article
Cite this article
Thate, A., Meyer, D.K. Effect of ω-conotoxin GVIA on release of 3H-γ-aminobutyric acid from slices of rat neostriatum. Naunyn-Schmiedeberg's Arch Pharmacol 339, 359–361 (1989). https://doi.org/10.1007/BF00173592
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173592